sive Shuttle Walk level attainment (p = 0.005) and total distance covered (p = 0.015). Angina frequency and severity remained unchanged in both groups, with the control demonstrating worsening SF-36 pain scale (63.43 8 22.28 vs. 55.46 8 23.98, p = 0.025). Cardiac rehabilitation participants showed improved Health Anxiety Questionnaire reassurance (1.71 8 1.72 vs. 1.14 8 1.23, p = 0.026) and York Beliefs anginal threat perception (12.42 8 4.58 vs. 14.35 8 4.73, p = 0.05) after cardiac rehabilitation. Physical measures were broadly unaffected. Conclusions: Cardiac rehabilitation can be prescribed to improve physical ability without affecting angina frequency or severity among patients with refractory angina.
Introduction
The majority of patients presenting with angina pectoris resulting from coronary heart disease (CHD) are successfully treated with interventions including coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) and medical management [1] . However, a growing number of patients experience persistent, refractory angina in spite of intervention and optimal medical treatment [2, 3] . Current estimates suggest as many as 10% of all patients diagnosed with CHD will develop refractory angina, highlighting an ever increasing population of patients with a symptomatic untreatable chronic disease [1] .
Previous studies have explored the effect of various therapeutic interventions, including stellate ganglion blocks [4] , electrical neuromodulation devices, such as transcutaneous electrical nerve stimulation [5] and spinal cord stimulation [6, 7] , enhanced external counterpulsation [8] , percutaneous myocardial laser revascularisation [9] and a specifically designed management program [10] . However, such treatments have failed to demonstrate a universal impact on the chest pain and dyspnoea associated with refractory angina.
In accordance with studies of patients with CHD, refractory angina is associated with increased psychological morbidity and a chronically impaired quality of life [10] . It has been suggested that interventions to reduce psychological distress have the potential to improve longterm cardiac prognosis [11] . Cardiac rehabilitation has been shown to improve depression [12] , anxiety [13] , and quality of life among patients with CHD [14] ; however, as many as 50% of patients undergoing cardiac rehabilitation following myocardial infarction (MI) suffer from clinically high levels of psychological distress [15] . A combined treatment package of outpatient counselling, cardiac rehabilitation and cognitive behavioural therapy has been shown to improve psychological morbidity and quality of life among refractory angina patients [16] . However, studies exploring the physiological and psychological impact of routinely available cardiac rehabilitation as a stand-alone intervention for refractory angina have not previously been undertaken.
The updated American Heart Association recommendations for exercise and training [17] advocates cardiac rehabilitation and supervised exercise training for patients with ongoing angina, previous history of CABG, MI, PCI and patients with existing cardiomyopathy. Meta-analysis has shown that exercise-based rehabilitation does not increase the risk of non-fatal MI, revascularisation, cardiac or all-cause mortality among existing CHD cardiac rehabilitation participants [18] . Cardiac rehabilitation has been recommended as a suitable treatment for refractory angina for improving myocardial perfusion and quality of life [2] , along with long-term prognosis and functional capacity [1] . Nevertheless, cardiac rehabilitation centres are reluctant to accept patients with ongoing angina or complicated cardiovascular history in spite of the duration or stability of the symptoms. Indeed, angina and heart failure are often used to exclude patients from cardiac rehabilitation [19] . It has been argued that cardiac rehabilitation should be made more widely available, as the benefits of cardiovascular exercise therapy should not be limited to the refined subgroup of cardiovascular patients currently admitted to cardiac rehabilitation [18] . However, the paucity of data and a lack of empirical research exploring the impact of exercise therapy among patients with refractory angina are prohibiting patients from participating in a potentially beneficial treatment program.
Therefore, this study was designed to establish whether an 8-week cardiac rehabilitation exercise program is an appropriate treatment option for patients with refractory angina. The primary end point was effect of cardiac rehabilitation on anxiety and depression, with secondary end points including physical and physiological functioning, symptom frequency and severity, and other measures of psychological morbidity and quality of life.
Methods
The study was designed as a randomised control trial and was approved by the Royal Brompton & Harefield NHS Foundation Trust Ethics Committee. All patients gave written informed consent. The use of group blinding was expressly forbidden by the local ethics committee due to issues relating to obtaining fully informed consent. Patients with the full diagnostic criteria for refractory angina who fulfilled the study inclusion criteria ( table 1 ) were recruited from cardiology outpatients, pain and specialised angina clinics at the Royal Brompton & Harefield NHS Foundation Trust. Eligible patients were also identified from the recent cardiac catheterisation lists and approached to participate by mail.
Following consent, patients were randomly assigned to complete either an 8-week cardiac rehabilitation and symptom monitoring program or 8-week symptom monitoring only control in addition to standard treatment. Randomisation was performed using 60 identical opaque brown sealed envelopes containing an equal number of paper strips marked 'Rehabilitation' or 'Monitoring'. Physical measurements were taken, including resting blood pressure, height, weight, fasting blood sample (lipid profile, glucose, haemoglobin, U&E, LFT, TFT), resting 12-lead ECG and a telemetry-monitored Progressive Shuttle Walk (PSW) exercise tolerance test [20] . All patients were then guided through and asked to complete a number of questionnaires (see the section 'Questionnaires' below), while the symptom diary was explained in detail. Patients randomised to the control arm were requested to start the symptom monitoring diary immediately, and to desist from any new self-motivated, independent exercise program while participating in the study. Adherence to this request was checked at each subsequent study visit. Patients randomised to cardiac rehabilitation were instructed to begin the diary the week of their first class.
Following the 8-week intervention, physical measurements and PSW tests were repeated, while patients returned the symptom monitoring diaries and completed a further set of questionnaires, identical to those completed at baseline, with supplementary questions relating to changes in medication, illnesses or hospitalisations during the 8-week intervention. The physical measurements, PSW test and questionnaires were completed a final time by all patients after a further 8-week follow-up period, where additional questions were asked relating to exercise participation and physical activity levels.
Questionnaires
The Health Anxiety Questionnaire (HAQ) [21] is comprised of four subscales, which measure health worry and preoccupation, fear of illness and death, reassurance-seeking behaviour and interference with life. The Hospital Anxiety and Depression Scale (HADS) [22] measures clinically significant anxiety and depression in general medical patients, while the SF-36 [23] is a general health questionnaire divided into different aspects of quality of life: physical functioning, physical role, bodily pain, general health, vitality, social functioning, emotional role and mental health. The York Angina Beliefs scale [24] is designed to uncover the patient's beliefs and possible misconceptions regarding chest pain symptoms and dyspnoea. Finally, patients were asked to complete the ENRICHD Social Support Instrument [25] , which assesses four key attributes of social support: emotional, instrumental, informational and appraisal. Patients were also asked questions relating to symptom severity and frequency, along with the year of diagnosis and the duration of suffering.
Cardiac Rehabilitation
The cardiac rehabilitation intervention was comprised of a standard 8-week group-based Phase III cardiac rehabilitation exercise program, which conformed to the British Association for Cardiac Rehabilitation guidelines [26] . The outpatient cardiovascular exercise program was designed to improve aerobic conditioning, functional capacity, muscular strength, endurance and flexibility. Participants were encouraged to attend the weekly health promotion seminars, covering topics including stress management, medication, physical activity and dietary advice, although due to the regional variation across current cardiac rehabilitation centres, this was not a mandatory component of the study. Study patients were amalgamated into existing classes (routine procedure due to the constant patient turnover in cardiac rehabilitation groups) and allocated on the basis of physical ability rather than diagnosis. Each cardiac rehabilitation class was approximately 80 min in duration, with patients moving through a circuit of activities, alternating between cardiovascular and active rest stations. The aim was for cardiac rehabilitation participants with normal left ventricular function to exercise at 60-75% of their age-predicted heart rate reserve, with a target of 40-60% if the patient presented with an ejection fraction of less than 40%.
The supporting home exercise program comprised of activities such as brisk walking, along with movement and strengthening exercises. Patients were requested to perform a minimum of one home-based cardiac rehabilitation session per week, while also improving their daily activity levels. Patients recorded their weekly home-based exercise participation, which was reviewed during each hospital-based cardiac rehabilitation session.
Symptom Monitoring
Both the cardiac rehabilitation and control groups were required to complete a symptom monitoring diary for the duration of the 8-week intervention period. All participants were asked to complete the diary each day, noting the symptoms they associated with their angina, severity of the attack, and activity and time of day of onset. Patients were instructed to grade their symptoms using a standard five-point pain scale. 
Statistics and Sample Size Calculation
The study was designed as randomised within-and betweensubjects design, comparing active with control and changes within both groups on each measure at all three study time points, using two-tailed tests. The data were analysed using one-way ANOVA, paired and independent Students' t tests and ANCOVA to determine between-group effects while controlling for baseline variation; overall comparisons of categorical data were performed using 2 test. Statistical significance level was set at p ! 0.05. Data are expressed as mean 8 standard deviation. In order to ensure a minimum 80% power with a 5% significance level, the mean group differences of each HADS and HAQ subscale from a previous cross-sectional study [27] (HADS depression: 2.1 8 3.5, n = 85; HAQ interference with life: 1.9 8 2.4, n = 50; total HAQ: 5.6 8 7.8, n = 65) were used to establish the average sample size required using the standard calculation and normogram [28] . Using these parameters, it was calculated that a sample size of 70 would enable the accurate assessment of cardiac rehabilitation as a treatment for patients with refractory angina.
Results
Forty-two patients with refractory angina (65.1 8 7.3 years) with an average cardiovascular history of 12.3 ( 8 8.7) years were consented into the study. Twenty-two patients (65.1 8 7.1 years) were randomised to cardiac rehabilitation and 20 (65.1 8 7.7 years, p = 0.98) to the control. The risk factors and cardiovascular history of the patient cohort are shown in table 2 . There were no significant differences in the cardiovascular medications (statins, aspirin, beta-blockers, diuretics, ACE inhibitors, calcium channel blockers, nitrates, potassium channel activators, antiplatelet therapy and GTN) used by both groups ( table 3 ) . Seventeen percent of patients were female and equally represented in both groups. Two patients randomised to cardiac rehabilitation withdrew following randomisation (family problems, comorbidities) while a further patient was withdrawn from the study after suffering a non-ST-elevation MI and cerebrovascular accident following randomisation but prior to starting cardiac rehabilitation. Two patients participating in the rehabilitation program suffered medical complications during the exercise classes (panic attack, vasovagal following coughing fit related to previously undiagnosed bronchiectasis) and were admitted for observation. Both were discharged without event and completed the study. Therefore, 19 patients randomised to cardiac rehabilitation successfully completed the 8-week cardiac rehabilitation program completing an average of seven (range 3-12) classes, along with comparable number of home exercise sessions (range 2-12). Twenty patients randomised to the symptom monitoring control completed the study.
Physical Ability
There were no baseline differences between the groups on either measure of physical ability ( table 4 ) . Nevertheless, when controlling for baseline variation, there was a significant difference between the groups' PSW level attainment (p = 0.005), with cardiac rehabilitation participants (4.19 8 1.15 vs. 5.44 8 1.50, p ! 0.001) showing greater improvements than controls (4.04 8 1.3 vs. 4.50 8 1.2, p = 0.002). This is also reflected in the PSW distance covered, with a significant difference between the groups (p = 0.015) and within the groups at each time point ( fig. 1 ). 
Angina Frequency and Severity
The angina diaries showed no baseline differences between groups on either angina frequency or severity ( table 4 ). This continued throughout the study, and while a trend towards reduced angina severity was noted within the rehab group (1.82 8 0.88 vs. 1.21 8 1.28, p = 0.07), no significant differences were found between or within either group at any time point.
Physiological Measures
Patients randomised to the control group had a higher waist/hip ratio, heart rate and fasting plasma glucose at baseline than the cardiac rehabilitation group ( table 4 ) However, controls demonstrated reduced HADS anxiety (7.25 8 4.25 vs. 6.18 8 3.52, p = 0.04), total HADS (13.12 8 7.09 vs. 11.75 8 6.49, p = 0.05) and HAQ health worry (6.94 8 4.53 vs. 5.00 8 2.95, p = 0.013) at visit two not found within the cardiac rehabilitation group. Controls also showed greater improvements in SF-36 physical health than the cardiac rehabilitation group at visit two while controlling for baseline variation (p = 0.05). Difference in the PSW test distance covered between the study groups at all three time points in the study.
Discussion
As the number of patients with chronic refractory angina pectoris continues to rise [1] , providing patients with capacity to maintain and perform the activities of daily life has become paramount. The results of this pilot study suggest that cardiac rehabilitation can help to fulfil this role. The current pilot study has determined that patients with refractory angina can often successfully participate in an established Phase III cardiac rehabilitation program without serious adverse event. Furthermore, these pilot data suggest that refractory angina patients can significantly improve their physical ability through cardiac rehabilitation without compromising the frequency or severity of existing angina. Global pain perception was unaffected among patients participating in cardiac rehabilitation, highlighting the potential for this modality to improve physical function without aggravating any existing comorbidities. Improving physical function without a concurrent increase in angina frequency may also be related to the improvements in psychological morbidity found among those participating in cardiac rehabilitation. Demonstrating that an existing, routinely available treatment program designed for patients in the early stages of cardiovascular disease could also benefit patients with long-term refractory angina may prove invaluable to both patients and clinicians struggling to manage this difficult, uncompromising condition.
Cardiac rehabilitation has previously been advocated as a treatment for refractory angina [1] , although there are very few studies exploring the impact of exercise training among this patient group. In spite of recent guidelines promoting cardiac rehabilitation for the treatment of conditions other than recently diagnosed cardiovascular disease and intervention [17] , cardiac rehabilitation has recently been described as 'vastly underutilized' [29] . The continued physical activity required to maintain the benefits of any cardiac rehabilitation program has been identified as a barrier to primary participation and referral [2] , while the patient's fear of exposure to risk and increased pain has also been identified as a shortcoming [18] . Participation and adherence rates for routine patients participating in cardiac rehabilitation remains low [30] , with women, the elderly and ethnic minorities specifically identified as less likely to take part [31] . However, any bias in participation among certain groups with refractory angina has not yet been established. Further research is required to assess barriers to utilisation of cardiac rehabilitation among patients with refractory angina, and strategies to enhance accessibility and adherence rates.
Study Limitations
By design, pilot studies are intended primarily to assess the feasibility of performing a definitive evaluation of the study aims and, secondarily and if possible, to provide some evidence favouring the appropriateness of undertaking a definitive study. This pilot study has demonstrated the feasibility of applying cardiac rehabilitation therapy to patients with angina refractory to conventional therapy and suggests that benefit result from such application. The true impact of cardiac rehabilitation in patients with refractory angina now must be tested in a larger, more definitive study. Our results strongly suggest that this is a reasonable and potentially beneficial next step.
The strength of conclusions inferable from this study is limited in part by the relatively small sample size. Sample sizes are generally small in pilot studies but, in addition, in this study, the projected sample size was not achieved. Thus, power to test underlying hypotheses was inherently limited, possibly explaining the failure to demonstrate statistically significant differences among subgroups for certain outcomes of interest. Factors limiting recruitment included the relative geographic isolation of the rehabilitation centre, the impact of patients' existing comorbidities and patients' fear of exacerbating existing symptoms by exercise. In addition, failure to demonstrate inter-group differences may have resulted in part from concurrent improvements in physical parameters in both control and treated groups, possibly related to increasing familiarity with the environs over the duration of the study. Similar levels of contact and interaction have been associated with improved psychological morbidity and a number of physical measures among a comparable control [32] . The gender inequality in patient recruitment may reflect sex bias among refractory angina patients or the established non-participation of women in cardiac rehabilitation [29] . Future studies should employ a larger representative patient population to further explore the benefit of cardiac rehabilitation on physical functioning, psychological wellbeing and quality of life among patients with refractory angina.
Conclusions
The challenge of managing the ever increasing numbers of patients presenting with refractory angina requires existing treatments to be refined, and emerging therapies to be embraced. Increasing life expectancy without enabling patients to improve or maintain their physical ability robs sufferers of the dignity of managing daily life. Cardiac rehabilitation is an established, assessable treatment program familiar to both patients and clinicians alike. This pilot study suggests that the application of this technique may provide a substantial impact on patients' physical ability, without compromising comorbid pain, angina or risk of serious adverse event. A larger, more definitive study now is justified to support the very promising potential of cardiac rehabilitation for patients with refractory angina, providing them the opportunity to reestablish a fulfilling, active life.
